7-15366183-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004320.2(AGMO):āc.1114A>Gā(p.Ile372Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000304 in 1,609,338 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I372M) has been classified as Uncertain significance.
Frequency
Consequence
NM_001004320.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AGMO | NM_001004320.2 | c.1114A>G | p.Ile372Val | missense_variant | 11/13 | ENST00000342526.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AGMO | ENST00000342526.8 | c.1114A>G | p.Ile372Val | missense_variant | 11/13 | 1 | NM_001004320.2 | P1 | |
AGMO | ENST00000407277.6 | c.7A>G | p.Ile3Val | missense_variant | 1/3 | 3 | |||
AGMO | ENST00000418075.1 | c.40A>G | p.Ile14Val | missense_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000652 AC: 16AN: 245444Hom.: 0 AF XY: 0.0000377 AC XY: 5AN XY: 132620
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1457240Hom.: 1 Cov.: 30 AF XY: 0.0000262 AC XY: 19AN XY: 724668
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152098Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.1114A>G (p.I372V) alteration is located in exon 11 (coding exon 11) of the AGMO gene. This alteration results from a A to G substitution at nucleotide position 1114, causing the isoleucine (I) at amino acid position 372 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at